Andrew joins CHASE clinical as Business Development Director and brings a wealth of clinical and commercial experience to our patient recruitment services, focusing on studies from phase IIb onwards.
Prior to joining CHASE clinical, Andrew worked as Business Development Director at Parexel.
His career spans Senior Management roles for a variety of major multinational pharmaceutical and healthcare companies. He started his career as a Hospital Pharmacist before joining Eli Lilly in 1997 as a Healthcare Development Manager.
From 1999 until 2007, Andrew worked for AstraZeneca in senior roles, including National Sales Management. He then went on to work as a Clinical Effectiveness Consultant for Pfizer, before becoming NHS Commercial Director for IQVIA between 2012 and 2017.